136 related articles for article (PubMed ID: 38687170)
1. Photoactivated full-API nanodrug (FAND): harnessing transition metal complexes and MTH1 inhibitor for enhanced DNA damage in cancer cells.
Zhu H; Cui M; Tang Q; Zhao H; Zhang P; Zeng S; Li W; Zhou Q; Zhang J; Chen Y
Biomater Sci; 2024 Jun; 12(12):3154-3162. PubMed ID: 38687170
[TBL] [Abstract][Full Text] [Related]
2. Fusion of photodynamic therapy and photoactivated chemotherapy: a novel Ru(II) arene complex with dual activities of photobinding and photocleavage toward DNA.
Chen Y; Lei W; Jiang G; Hou Y; Li C; Zhang B; Zhou Q; Wang X
Dalton Trans; 2014 Nov; 43(41):15375-84. PubMed ID: 25188424
[TBL] [Abstract][Full Text] [Related]
3. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells.
Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H
Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841
[TBL] [Abstract][Full Text] [Related]
4. Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma.
Huang X; Chen J; Wu W; Yang W; Zhong B; Qing X; Shao Z
Acta Biomater; 2020 Jun; 109():229-243. PubMed ID: 32294550
[TBL] [Abstract][Full Text] [Related]
5. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.
Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ
J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123
[TBL] [Abstract][Full Text] [Related]
6. To cage or to be caged? The cytotoxic species in ruthenium-based photoactivated chemotherapy is not always the metal.
Cuello-Garibo JA; Meijer MS; Bonnet S
Chem Commun (Camb); 2017 Jun; 53(50):6768-6771. PubMed ID: 28597879
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives.
Lee SY; Kim CY; Nam TG
Drug Des Devel Ther; 2020; 14():5375-5392. PubMed ID: 33299303
[TBL] [Abstract][Full Text] [Related]
8. Strained ruthenium complexes are potent light-activated anticancer agents.
Howerton BS; Heidary DK; Glazer EC
J Am Chem Soc; 2012 May; 134(20):8324-7. PubMed ID: 22553960
[TBL] [Abstract][Full Text] [Related]
9. MTH1 inhibitor amplifies the lethality of reactive oxygen species to tumor in photodynamic therapy.
Zhao L; Li J; Su Y; Yang L; Chen L; Qiang L; Wang Y; Xiang H; Tham HP; Peng J; Zhao Y
Sci Adv; 2020 Mar; 6(10):eaaz0575. PubMed ID: 32181355
[TBL] [Abstract][Full Text] [Related]
10. Diatom-like silica-protein nanocomposites for sustained drug delivery of ruthenium polypyridyl complexes.
Shi H; Lou J; Lin S; Wang Y; Hu Y; Zhang P; Liu Y; Zhang Q
J Inorg Biochem; 2021 Aug; 221():111489. PubMed ID: 34000586
[TBL] [Abstract][Full Text] [Related]
11. Ir(III) and Ru(II) Complexes in Photoredox Catalysis and Photodynamic Therapy: A New Paradigm towards Anticancer Applications.
Raza MK; Noor A; Samantaray PK
Chembiochem; 2021 Dec; 22(23):3270-3272. PubMed ID: 34558773
[TBL] [Abstract][Full Text] [Related]
12. Ruthenium-Based Photoactivated Chemotherapy.
Bonnet S
J Am Chem Soc; 2023 Nov; 145(43):23397-23415. PubMed ID: 37846939
[TBL] [Abstract][Full Text] [Related]
13. Two novel BODIPY-Ru(ii) arene dyads enabling effective photo-inactivation against cancer cells.
Wang T; Hou Y; Chen Y; Li K; Cheng X; Zhou Q; Wang X
Dalton Trans; 2015 Jul; 44(28):12726-34. PubMed ID: 26087131
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium-Cathepsin Inhibitor Conjugates for Green Light-Activated Photodynamic Therapy and Photochemotherapy.
Denison M; Garcia SP; Ullrich A; Podgorski I; Gibson H; Turro C; Kodanko JJ
Inorg Chem; 2024 Apr; 63(17):7973-7983. PubMed ID: 38616353
[TBL] [Abstract][Full Text] [Related]
15. Luminescent naphthalimide-tagged ruthenium(ii)-arene complexes: cellular imaging, photocytotoxicity and transferrin binding.
Srivastava P; Verma M; Kumar A; Srivastava P; Mishra R; Sivakumar S; Patra AK
Dalton Trans; 2021 Mar; 50(10):3629-3640. PubMed ID: 33625414
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action of Ru(ii) polypyridyl complexes in living cells upon light irradiation.
Jakubaszek M; Goud B; Ferrari S; Gasser G
Chem Commun (Camb); 2018 Nov; 54(93):13040-13059. PubMed ID: 30398487
[TBL] [Abstract][Full Text] [Related]
17. Bithiophene-Functionalized Infrared Two-Photon Absorption Metal Complexes as Single-Molecule Platforms for Synergistic Photodynamic, Photothermal, and Chemotherapy.
Li XL; Wang MF; Zeng LZ; Li GK; Zhao RY; Liu FD; Li Y; Yan YF; Liu Q; Li Z; Zhang H; Ren X; Gao F
Angew Chem Int Ed Engl; 2024 Jul; 63(27):e202402028. PubMed ID: 38656658
[TBL] [Abstract][Full Text] [Related]
18. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers.
Mo J; Mai Le NP; Priefer R
Eur J Med Chem; 2021 Dec; 225():113770. PubMed ID: 34403979
[TBL] [Abstract][Full Text] [Related]
20. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]